• Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
Quantisnow Logo
  • Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
Dashboard
    Quantisnow Logo

    © 2025 quantisnow.com
    Democratizing insights since 2022

    Services
    Live news feedsRSS FeedsAlerts
    Company
    AboutQuantisnow PlusContactJobs
    Legal
    Terms of usePrivacy policyCookie policy

    MedTechVets Appoints Patrice Sutherland, Enterprise Executive Director at Integra LifeScience, as New Board Chairperson

    10/24/22 12:00:00 PM ET
    $ABMD
    Medical/Dental Instruments
    Health Care
    Get the next $ABMD alert in real time by email

    Succeeds Derek Herrera after two-year term

    Patrice Sutherland, enterprise executive director at Integra Life Sciences, has been appointed Chairperson of the Board of Directors for MedTechVets, a nonprofit organization that helps military Veterans transition and gain employment at Medical Technology and Life Science companies. This announcement is being made today during the Plenary Luncheon at AdvaMed's MedTech Conference 2022, which is taking place through Oct. 26 at the Boston Convention and Exhibition Center. A U.S. Army combat Veteran, Sutherland succeeds Derek Herrera and will assume the role on January 1, 2023.

    This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20221024005178/en/

    Patrice Sutherland (Photo: Business Wire)

    Patrice Sutherland (Photo: Business Wire)

    "I am humbled and honored to have been asked to take on this very special role," said Sutherland. "Our transitioning Veterans are a treasure and our goal at MedTechVets is to help them be well prepared and supported as they move to their next phase of life and continue to be bold and brave in the corporate world of Medical Technologies."

    "It has been a joy to serve the community as the chair of MedTechVets and I am so excited to congratulate Patrice as the new Chair. I am confident in Patrice to lead us and take the organization to the next level," said Herrera, who is CEO of Bright Uro. During his tenure leading MedTechVets throughout COVID, Herrera oversaw the launch of the MedTechVets Academy, a seven-week virtual program that helps bridge military and civilian employment by providing mentorship, job search planning and networking and other support services for careers in the Medical Technology and Life Sciences industries.

    "I am thrilled to have Patrice Sutherland take on this role, knowing that her leadership skills and experience will enable MedTechVets to help more Veterans find meaningful employment after their military service," said Mike Minogue, President, Chairman and Chief Executive Officer of Abiomed and founder of MedTechVets. "I would like to thank Derek for his immense contributions, including the launch of MedTechVets Academy, which will allow for the continued growth of MedTechVets and its impact." Minogue was the first MedTechVets board chair and served an eight-year term.

    Sutherland was awarded the Bronze Star Medal during her time in the Army. She is also a Six Sigma Black Belt and has earned national sales awards for leadership and sales results throughout her career. Sutherland received her bachelor's degree in chemistry and engineering from the United States Military Academy at West Point and her MBA from Rice Business – Jones Graduate School of Business at Rice University. Since joining the MedTechVets board in 2021, Sutherland has personally helped many Veterans transition to careers in the Medical Technology and Life Sciences industries.

    "I am pleased to welcome Patrice Sutherland as the new chair of MedTechVets. She is taking the helm of a tremendous organization with a proven track record of connecting Veterans with exciting career opportunities in medtech, and as sponsors of MedTechVets and this worthy mission, we look forward to working with her," said Scott Whitaker, AdvaMed President and CEO. "I also want to thank Derek Herrera for his leadership and for his dedication to growing the organization and ensuring it reaches more transitioning servicemembers. MedTechVets has improved the lives of countless Veterans and has given our member companies access to a dedicated and skilled workforce."

    About MedTechVets

    MedTechVets is a 501(c)(3) nonprofit serving Veterans during career transition and beyond.

    Our Vision is to build a bridge to help Veterans find meaningful employment in the Medical Technology Industry. We bridge the gap for Veterans by providing personalized career transition services, mentorship, and career development guidance. We serve Veterans who plan to enter the MedTech, Life Sciences, Pharmaceutical, or Medical Device industries. MedTechVets is proud to be endorsed by Advanced Medical Technology Association (AdvaMed).

    About AdvaMed

    AdvaMed is the world's largest Medical Technology association, representing device, diagnostics, and digital technology manufacturers that are transforming health care through earlier disease detection, less invasive procedures, and more effective treatments.

    About Abiomed

    Based in Danvers, Massachusetts, USA, Abiomed (NASDAQ:ABMD) is a leading provider of Medical Technology that provides circulatory support and oxygenation. Our products are designed to enable the heart to rest and recover by improving blood flow and/or provide sufficient oxygenation to those in respiratory failure. For additional information, please visit abiomed.com.

    View source version on businesswire.com: https://www.businesswire.com/news/home/20221024005178/en/

    Get the next $ABMD alert in real time by email

    Chat with this insight

    Save time and jump to the most important pieces.

    Recent Analyst Ratings for
    $ABMD

    DatePrice TargetRatingAnalyst
    11/2/2022$235.00 → $380.00Underweight → Equal-Weight
    Morgan Stanley
    11/2/2022$355.00 → $388.00Buy → Hold
    Deutsche Bank
    10/13/2022$300.00Buy
    Mizuho
    4/6/2022$330.00Peer Perform
    Wolfe Research
    2/4/2022$292.00 → $275.00Underweight
    Morgan Stanley
    2/4/2022$345.00 → $325.00Market Perform
    SVB Leerink
    1/7/2022$269.00 → $292.00Underweight
    Morgan Stanley
    8/6/2021$335.00 → $375.00Market Perform
    SVB Leerink
    More analyst ratings

    $ABMD
    Analyst Ratings

    Analyst ratings in real time. Analyst ratings have a very high impact on the underlying stock. See them live in this feed.

    See more
    • Abiomed upgraded by Morgan Stanley with a new price target

      Morgan Stanley upgraded Abiomed from Underweight to Equal-Weight and set a new price target of $380.00 from $235.00 previously

      11/2/22 9:11:07 AM ET
      $ABMD
      Medical/Dental Instruments
      Health Care
    • Abiomed downgraded by Deutsche Bank with a new price target

      Deutsche Bank downgraded Abiomed from Buy to Hold and set a new price target of $388.00 from $355.00 previously

      11/2/22 6:09:28 AM ET
      $ABMD
      Medical/Dental Instruments
      Health Care
    • Mizuho initiated coverage on Abiomed with a new price target

      Mizuho initiated coverage of Abiomed with a rating of Buy and set a new price target of $300.00

      10/13/22 7:17:59 AM ET
      $ABMD
      Medical/Dental Instruments
      Health Care

    $ABMD
    Financials

    Live finance-specific insights

    See more
    • Abiomed Announces Second Quarter Revenue of $266 Million, up 11% in Constant Currency*, up 7% on a Reported Basis Year Over Year

      ABIOMED, Inc. (NASDAQ:ABMD), a leader in breakthrough heart, lung and kidney support technologies, today announces financial results for the quarter ended September 30, 2022. Second Quarter 2023 Financial Highlights: Revenue of $266 million, an increase of 11% in constant currency, or 7% on a reported basis. This represents Abiomed's 7th consecutive quarter of double-digit constant currency growth. Worldwide product revenue of $253 million, an increase of 11% in constant currency, or 7% on a reported basis. Within the quarter, procedural volumes were impacted in July due to extended physician vacations, coupled with ongoing hospital labor shortages. The company saw an improvement in pa

      11/1/22 7:00:00 AM ET
      $ABMD
      $JNJ
      Medical/Dental Instruments
      Health Care
      Biotechnology: Pharmaceutical Preparations
    • Johnson & Johnson to Acquire Abiomed

      Strengthens Johnson & Johnson's MedTech Business with the Addition of Abiomed, a World-Leader in Heart Recovery Transaction to Bring Lifesaving Innovations to More Patients with Unmet Need Expected to Enhance Johnson & Johnson's Near- and Long-Term Sales and Earnings Growth; Accretive to Adjusted Earnings beginning in 2024 Conference Call at 8:00 a.m. ET To Discuss Details of the Transaction Johnson & Johnson (NYSE:JNJ), the world's largest, most diversified healthcare products company, and Abiomed (NASDAQ:ABMD), a world leader in breakthrough heart, lung and kidney support technologies, today announced that they have entered into a definitive agreement under which Johnson & Johnson wil

      11/1/22 6:30:00 AM ET
      $ABMD
      $JNJ
      Medical/Dental Instruments
      Health Care
      Biotechnology: Pharmaceutical Preparations
    • Abiomed Second Quarter Fiscal 2023 Earnings and Conference Call Notification

      Abiomed, Inc. (NASDAQ:ABMD) announced that on Tuesday, November 1, 2022, the Company will release financial results for the second quarter of the fiscal year 2023. The Company will host a conference call to discuss the results on Tuesday, November 1, 2022 at 8:00 a.m. ET. Michael R. Minogue, Chairman, President and Chief Executive Officer and Todd Trapp, Chief Financial Officer, will host the conference call. To listen to the call live, please tune into the webcast via https://events.q4inc.com/attendee/493387843 or dial (844) 200-6205; the international number is (929) 526-1599 access code 367357. A replay of this conference call will be available until Tuesday, November 8, 2022. The repla

      10/13/22 7:00:00 AM ET
      $ABMD
      Medical/Dental Instruments
      Health Care

    $ABMD
    Large Ownership Changes

    This live feed shows all institutional transactions in real time.

    See more
    • SEC Form SC 13G/A filed by ABIOMED Inc. (Amendment)

      SC 13G/A - ABIOMED INC (0000815094) (Subject)

      1/6/23 6:39:54 AM ET
      $ABMD
      Medical/Dental Instruments
      Health Care
    • SEC Form SC 13G filed by ABIOMED Inc.

      SC 13G - ABIOMED INC (0000815094) (Subject)

      12/29/22 4:03:01 PM ET
      $ABMD
      Medical/Dental Instruments
      Health Care
    • SEC Form SC 13G/A filed by ABIOMED Inc. (Amendment)

      SC 13G/A - ABIOMED INC (0000815094) (Subject)

      2/9/22 3:16:00 PM ET
      $ABMD
      Medical/Dental Instruments
      Health Care

    $ABMD
    Insider Trading

    Insider transactions reveal critical sentiment about the company from key stakeholders. See them live in this feed.

    See more
    • SEC Form 4: Sutter Martin P returned 123,370 shares to the company, closing all direct ownership in the company

      4 - ABIOMED INC (0000815094) (Issuer)

      12/27/22 8:47:48 PM ET
      $ABMD
      Medical/Dental Instruments
      Health Care
    • SEC Form 4: Puhy Dorothy E returned 14,590 shares to the company, closing all direct ownership in the company

      4 - ABIOMED INC (0000815094) (Issuer)

      12/27/22 8:44:35 PM ET
      $ABMD
      Medical/Dental Instruments
      Health Care
    • SEC Form 4: Trapp Todd A returned 14,166 shares to the company, closing all direct ownership in the company

      4 - ABIOMED INC (0000815094) (Issuer)

      12/27/22 8:41:11 PM ET
      $ABMD
      Medical/Dental Instruments
      Health Care

    $ABMD
    SEC Filings

    See more
    • SEC Form 15-12G filed by ABIOMED Inc.

      15-12G - ABIOMED INC (0000815094) (Filer)

      1/3/23 8:30:58 AM ET
      $ABMD
      Medical/Dental Instruments
      Health Care
    • SEC Form S-8 POS filed by ABIOMED Inc.

      S-8 POS - ABIOMED INC (0000815094) (Filer)

      12/22/22 4:46:31 PM ET
      $ABMD
      Medical/Dental Instruments
      Health Care
    • SEC Form S-8 POS filed by ABIOMED Inc.

      S-8 POS - ABIOMED INC (0000815094) (Filer)

      12/22/22 4:46:02 PM ET
      $ABMD
      Medical/Dental Instruments
      Health Care

    $ABMD
    Press Releases

    Fastest customizable press release news feed in the world

    See more
    • Dr. Mehdi H. Shishehbor Appointed Chief Medical Officer of Inquis Medical

      Renowned vascular disease expert joins Silicon Valley clinical stage medical device company developing next-generation thrombectomy technology Inquis Medical also announces appointment of Bruce Shook, serial medtech entrepreneur, to Board of Directors REDWOOD CITY, Calif., July 12, 2023 (GLOBE NEWSWIRE) -- Inquis Medical, Inc., a privately held medical device company focused on peripheral vascular innovations, today announced the appointment of distinguished interventional cardiologist and scholar, Mehdi H. Shishehbor, DO, MPH, Ph.D., as Chief Medical Officer. Dr. Shishehbor is the President of University Hospitals Harrington Heart and Vascular Institute where he is the Angela and Ja

      7/12/23 9:00:00 AM ET
      $STIM
      $ABMD
      Medical/Dental Instruments
      Health Care
    • FDA Approves Impella ECP Pivotal Heart Pump and First Patients Enrolled in Pivotal Clinical Trial

      Abiomed (NASDAQ:ABMD) announces the United States Food and Drug Administration (FDA) has approved the version of Impella ECP that will be used in the Impella ECP Pivotal Trial, and the first two patients have been enrolled in the trial. Amir Kaki, MD, director of mechanical circulatory support at Ascension St. John Hospital in Detroit, led the procedures. This single-arm, prospective, multi-center trial will evaluate the rate of major adverse cardiovascular and cerebrovascular events (MACCE) in adult patients who receive Impella ECP support during an elective or urgent high-risk percutaneous coronary intervention (PCI). This press release features multimedia. View the full release here: htt

      12/21/22 9:00:00 AM ET
      $ABMD
      Medical/Dental Instruments
      Health Care
    • Steel Dynamics Set to Join S&P 500; Super Micro Computer to Join S&P MidCap 400

      NEW YORK, Dec. 19, 2022 /PRNewswire/ -- S&P MidCap 400 constituent Steel Dynamics Inc. (NASD:STLD) will replace Abiomed Inc. (NASD:ABMD) in the S&P 500 and Super Micro Computer Inc. (NASD:SMCI) will replace Steel Dynamics in the S&P MidCap 400 effective prior to the opening of trading on Thursday, December 22. S&P 500 constituent Johnson & Johnson (NYSE:JNJ) is acquiring Abiomed in a deal expected to close soon pending final conditions.  Following is a summary of the changes that will take place prior to the open of trading on the effective date: Effective Date Index Name  Action Company Name Ticker GICS Sector December 22, 2022 S&P 500 Addition Steel Dynamics STLD Materials S&P 500 Deletion

      12/19/22 6:35:00 PM ET
      $ABMD
      $JNJ
      $SMCI
      $SPGI
      Medical/Dental Instruments
      Health Care
      Biotechnology: Pharmaceutical Preparations
      Computer Manufacturing

    $ABMD
    Leadership Updates

    Live Leadership Updates

    See more
    • Dr. Mehdi H. Shishehbor Appointed Chief Medical Officer of Inquis Medical

      Renowned vascular disease expert joins Silicon Valley clinical stage medical device company developing next-generation thrombectomy technology Inquis Medical also announces appointment of Bruce Shook, serial medtech entrepreneur, to Board of Directors REDWOOD CITY, Calif., July 12, 2023 (GLOBE NEWSWIRE) -- Inquis Medical, Inc., a privately held medical device company focused on peripheral vascular innovations, today announced the appointment of distinguished interventional cardiologist and scholar, Mehdi H. Shishehbor, DO, MPH, Ph.D., as Chief Medical Officer. Dr. Shishehbor is the President of University Hospitals Harrington Heart and Vascular Institute where he is the Angela and Ja

      7/12/23 9:00:00 AM ET
      $STIM
      $ABMD
      Medical/Dental Instruments
      Health Care
    • MedTechVets Appoints Patrice Sutherland, Enterprise Executive Director at Integra LifeScience, as New Board Chairperson

      Succeeds Derek Herrera after two-year term Patrice Sutherland, enterprise executive director at Integra Life Sciences, has been appointed Chairperson of the Board of Directors for MedTechVets, a nonprofit organization that helps military Veterans transition and gain employment at Medical Technology and Life Science companies. This announcement is being made today during the Plenary Luncheon at AdvaMed's MedTech Conference 2022, which is taking place through Oct. 26 at the Boston Convention and Exhibition Center. A U.S. Army combat Veteran, Sutherland succeeds Derek Herrera and will assume the role on January 1, 2023. This press release features multimedia. View the full release here: https

      10/24/22 12:00:00 PM ET
      $ABMD
      Medical/Dental Instruments
      Health Care
    • Dr. Paula A. Johnson Joins Abiomed Board of Directors

      Abiomed (NASDAQ:ABMD) announces the appointment of Paula A. Johnson, MD, MPH, to the Abiomed Board of Directors, effective immediately. Dr. Johnson will serve as a member of the Governance and Nominating Committee of the board. Following the appointment of Dr. Johnson, the board now comprises nine active directors. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20210428005332/en/Dr. Paula A. Johnson joins the Abiomed Board of Directors (Photo: Business Wire) "Dr. Johnson is known internationally as a leading expert in healthcare, medical research and health policy, especially for her work advancing the health of women," said Michae

      4/28/21 8:03:00 AM ET
      $ABMD
      Medical/Dental Instruments
      Health Care